Measuring glomerular filtration rate in the intensive care unit: No substitutes please

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Acute kidney injury (AKI), due to its increasing incidence, associated morbidity and mortality, and potential for development of chronic kidney disease with acceleration to end-stage renal disease, has become of major interest to nephrologists and critical care physicians. The development of biomarkers to diagnose AKI, quantify risk and predict prognosis is receiving considerable attention. Yet techniques to accurately assess functional changes within patients still rely on the use of an insensitive marker (creatinine), creatinine-based estimating equations and unreliable urinary tests. Therefore, it is critical that functional tests be developed and used in combination with biomarkers, thus allowing improved care in AKI and chronic kidney disease patient populations.

Original languageEnglish
Article number181
JournalCritical Care
Volume17
Issue number5
DOIs
StatePublished - Sep 4 2013

Fingerprint

Glomerular Filtration Rate
Acute Kidney Injury
Intensive Care Units
Chronic Renal Insufficiency
Creatinine
Biomarkers
Critical Care
Chronic Kidney Failure
Morbidity
Physicians
Mortality
Incidence
Population

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine
  • Medicine(all)

Cite this

Measuring glomerular filtration rate in the intensive care unit : No substitutes please. / Molitoris, Bruce.

In: Critical Care, Vol. 17, No. 5, 181, 04.09.2013.

Research output: Contribution to journalArticle

@article{740a0ffb33e6433b9a2bd99d1eef497e,
title = "Measuring glomerular filtration rate in the intensive care unit: No substitutes please",
abstract = "Acute kidney injury (AKI), due to its increasing incidence, associated morbidity and mortality, and potential for development of chronic kidney disease with acceleration to end-stage renal disease, has become of major interest to nephrologists and critical care physicians. The development of biomarkers to diagnose AKI, quantify risk and predict prognosis is receiving considerable attention. Yet techniques to accurately assess functional changes within patients still rely on the use of an insensitive marker (creatinine), creatinine-based estimating equations and unreliable urinary tests. Therefore, it is critical that functional tests be developed and used in combination with biomarkers, thus allowing improved care in AKI and chronic kidney disease patient populations.",
author = "Bruce Molitoris",
year = "2013",
month = "9",
day = "4",
doi = "10.1186/cc12876",
language = "English",
volume = "17",
journal = "Critical Care",
issn = "1466-609X",
publisher = "Springer Science + Business Media",
number = "5",

}

TY - JOUR

T1 - Measuring glomerular filtration rate in the intensive care unit

T2 - No substitutes please

AU - Molitoris, Bruce

PY - 2013/9/4

Y1 - 2013/9/4

N2 - Acute kidney injury (AKI), due to its increasing incidence, associated morbidity and mortality, and potential for development of chronic kidney disease with acceleration to end-stage renal disease, has become of major interest to nephrologists and critical care physicians. The development of biomarkers to diagnose AKI, quantify risk and predict prognosis is receiving considerable attention. Yet techniques to accurately assess functional changes within patients still rely on the use of an insensitive marker (creatinine), creatinine-based estimating equations and unreliable urinary tests. Therefore, it is critical that functional tests be developed and used in combination with biomarkers, thus allowing improved care in AKI and chronic kidney disease patient populations.

AB - Acute kidney injury (AKI), due to its increasing incidence, associated morbidity and mortality, and potential for development of chronic kidney disease with acceleration to end-stage renal disease, has become of major interest to nephrologists and critical care physicians. The development of biomarkers to diagnose AKI, quantify risk and predict prognosis is receiving considerable attention. Yet techniques to accurately assess functional changes within patients still rely on the use of an insensitive marker (creatinine), creatinine-based estimating equations and unreliable urinary tests. Therefore, it is critical that functional tests be developed and used in combination with biomarkers, thus allowing improved care in AKI and chronic kidney disease patient populations.

UR - http://www.scopus.com/inward/record.url?scp=84887517439&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84887517439&partnerID=8YFLogxK

U2 - 10.1186/cc12876

DO - 10.1186/cc12876

M3 - Article

C2 - 24004539

AN - SCOPUS:84887517439

VL - 17

JO - Critical Care

JF - Critical Care

SN - 1466-609X

IS - 5

M1 - 181

ER -